Streptokinase (strepterase)

Streptokinese is an oral antithrombolytic remedy, used to treat various diseases such as deep vein thrombosis or pulmonary embolism in adults, for example, because it accelerates and facilitates the destruction of clots that clog blood vessels.

Streptokinase is marketed by the CSL Behring laboratory and is known commercially as strepterase.

  • Streptokinesa is indicated for the treatment of deep vein thrombosis.
  • Pulmonary embolism.
  • Embolism.
  • Acute myocardial infarction.
  • Chronic obstructive arterial disease.
  • Arterial thrombosis and occlusion of the central vein or artery of the retina of the eye.

The price of streptokinse varies between 181 and 996 reais, depending on the dose.

Streptokine should be administered through the vein or artery and the dose should be indicated by your doctor, as it varies depending on the disease to be treated.

The main side effects of streptokinesa include severe spontaneous bleeding, brain hemorrhage, redness and itching on the skin, fever, chills, low blood pressure and increased heart rate.

Streptokine is contraindicated in children under 18 years of age and in patients with hypersensitivity to the components of the formula, and its use during pregnancy or lactation should only be performed under medical supervision.

In addition, patients with internal bleeding, reduced blood clotting, recent stroke, skull surgery, skull tumor, recent head trauma, hemorrhage-prone tumor, hypertension greater than 200/100 mmHg, malformation of arteries or veins, aneurysm should not take streptokine. , pancreatitis, implantation of prostheses in a vein, oral anticoagulant treatment, severe liver or kidney problems, endocarditis, pericarditis, hemorrhagic tendency or recent major surgery.

Leave a Comment

Your email address will not be published. Required fields are marked *